Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN

Name: Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN
Published: 2021
License: Public Domain

Apellis Pharmaceuticals, Inc. · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

c3g, ic-mpgn, renal transplant, complement 3 glomerulopathy, complement 3 glomerulopathy (c3g), dense deposit disease (ddd), membranoproliferative glomerulonephritis, membranoproliferative glomerulonephritis (mpgn), immune complex membranoproliferative glomerulonephritis (ic-mpgn), c3 glomerulopathy, c3 glomerulonephritis, complement 3 glomerulonephritis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 843759
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.